Metformin does not enhance ovulation induction in clomiphene resistant polycystic ovary syndrome in clinical practice (Q35803853)

10 August 2017

Metformin does not enhance ovulation induction in clomiphene resistant polycystic ovary syndrome in clinical practice (English)

1 reference

polycystic ovary syndrome

10 August 2017

1 reference

1 reference

1 reference

1 reference

N D C Sturrock

1

1 reference

10 August 2017

B Lannon

series ordinal

2

1 reference

10 August 2017

T N Fay

series ordinal

3

1 reference

10 August 2017

language of work or name

English

0 references

publication date

1 May 2002

1 reference

British Journal of Clinical Pharmacology

10 August 2017

1 reference

10 August 2017

53

1 reference

10 August 2017

5

1 reference

10 August 2017

469-473

1 reference

Metformin increases the ovulatory rate and pregnancy rate from clomiphene citrate in patients with polycystic ovary syndrome who are resistant to clomiphene citrate alone

10 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1874363

Insulin secretion and insulin sensitivity in relation to glucose tolerance: lessons from the Botnia Study

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1874363

Metformin effects on clinical features, endocrine and metabolic profiles, and insulin sensitivity in polycystic ovary syndrome: a randomized, double-blind, placebo-controlled 6-month trial, followed by open, long-term clinical evaluation.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1874363

Effects of metformin on spontaneous and clomiphene-induced ovulation in the polycystic ovary syndrome

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1874363

An overview of metformin in the treatment of type 2 diabetes mellitus

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1874363

Metformin therapy in polycystic ovary syndrome reduces hyperinsulinemia, insulin resistance, hyperandrogenemia, and systolic blood pressure, while facilitating normal menses and pregnancy

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1874363

Effects of diet and metformin administration on sex hormone-binding globulin, androgens, and insulin in hirsute and obese women.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1874363

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1874363

Insulin stimulates androgen accumulation in incubations of ovarian stroma obtained from women with hyperandrogenism

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1874363

Effects of in-utero exposure to oral hypoglycaemic drugs

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1874363

Effect of dietery weight loss on sex steroid binding sex steroids, and gonadotropins in obese postmenopausal women

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1874363

Effect of long-term treatment with metformin added to hypocaloric diet on body composition, fat distribution, and androgen and insulin levels in abdominally obese women with and without the polycystic ovary syndrome.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1874363

The insulin-sensitizing agent troglitazone improves metabolic and reproductive abnormalities in the polycystic ovary syndrome.

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1874363

Can metformin reduce insulin resistance in polycystic ovary syndrome?

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1874363

Clinical and laboratory predictors of clomiphene response

25 September 2018

1 reference

12 December 2020

Diet-induced changes in sex hormone binding globulin and free testosterone in women with normal or polycystic ovaries: correlation with serum insulin and insulin-like growth factor-I

1 reference

12 December 2020

Detection of Functional Ovarian Hyperandrogenism in Women with Androgen Excess

1 reference

12 December 2020

Ovarian tumors in a cohort of infertile women

1 reference

12 December 2020

Congenital Malformations in Offspring of Diabetic Women Treated with Oral Hypoglycaemic Agents During Embryogenesis

1 reference

12 December 2020

10.1046/J.1365-2125.2002.01575.X

Identifiers

DOI

1 reference

10 August 2017

1 reference

10 August 2017

1 reference